Floatz logo

Hydrocortisone

Acute Leukemia Of Ambiguous Lineage

National Cancer Institute (NCI)Small moleculePhase 2Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
48/ 100
Competitive Position
73/ 100

Competitive context

42 Active assets in the Acute Leukemia Of Ambiguous Lineage cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
SWOG Cancer Research Network
Phase 2BB
L-Ofloxacin
Children's Oncology Group
Phase 3BB
CYTARABINE
SWOG Cancer Research Network
Phase 2B
METHOTREXATE
SWOG Cancer Research Network
Phase 2B
VINCRISTINE SULFATE
Children's Oncology Group
Phase 2B

View all 50 →

Same molecule, other indications

Hydrocortisone is also rated in:

congenital adrenal hyperplasiaActive
A
Indicative · Phase 4
81 / 100
View asset →
childhood acute lymphoblastic leukemiaActive
BB
Indicative · Phase 3
68 / 100
View asset →
adrenocortical insufficiencyActive
BB
Indicative · Phase 3
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →